Inovio Pharmaceuticals, Inc. is an American biotechnology company headquartered in Pennsylvania with a current market cap of 38.7 billion USD. It focuses on the development of DNA-based immunotherapies and vaccines for treating and preventing cancer and infectious diseases. The stock price of Inovio Pharmaceuticals Inc has been relatively stable over the past few days, with a 0.6494% increase on February 3rd as compared to its previous close at 1.54 USD. Between January 1st and February 3rd, the company’s market capitalization grew from 41.66 billion USD to 47.65 billion USD – an increase of 14%.
In terms of year-on-year performance, the stock price has increased by 12% since February 1st 2020 when it was valued at 1.38 USD per share while its market cap stood at 43.17 billion USD on that date. Moreover, the stock’s 50 day average price stands at 1.7 million USD while the 200 day average stands at 1.95 million USD – showing a slight drop in stock price over the last six months or so but still presenting a decent growth rate for investors over long term investment periods due to its current market capitalization growth rate trajectory this year so far..
